** Musk reveals how he hired Ashok Elluswamy as Tesla Autopilot Head

Ashok Elluswamy holds a bachelor’s degree in Electronics and Communication Engineering from the College of Engineering Guindy, Chennai

Elluswamy was actually the first employee to be hired for Tesla’s Autopilot team, with Musk actually using Twitter to ask people to apply for the role back in 2015.

** India gifts 5 lakh doses of Covaxin to Afghanistan

Wheat and medicines will also be sent as part of the humanitarian aid programme to the Taliban-ruled country

India began the new year by handing over half a million doses of COVID-19 vaccines to Afghanistan on Saturday. The consignment is part of a million-strong vaccine supply that will be completed within the coming weeks, the Ministry of External Affairs (MEA) has said. It will be one of the largest-ever humanitarian assistance projects from India to Afghanistan consisting of wheat and other medicines to be organised in coordination with U.N. agencies.

** American Association of Engineers of India Origin launches Innovation Center

The hub was inaugurated by Bill Foster, Congressman-IL, together with AAEIO President Gladson Varghese, President-Elect Ajit Pant, Vice President Nitin Maheshwari, and other board members.

** Amara Raja investing €10 million in European electric vehicle battery group

The investment is part of the Energy and Mobility strategy Amara Raja is pursuing to foray into new green technologies and solutions through expansion and investment

Amara Raja Batteries is investing €10 million in InoBat Auto, a European Group focused on research and development in the field of batteries for electric vehicles and production of lithium-ion battery cells as well as tailored and customs cells.

** Reliance New Energy Solar to acquire U.K.’s sodium-ion battery tech firm Faradion

Reliance New Energy Solar Ltd. (RNESL), a wholly owned subsidiary of Reliance Industries Ltd., said it has signed definitive agreements to acquire 100% shareholding in Faradion Ltd. (Faradion) for an enterprise value of GBP 100 million (around ₹1,000 crore).

In addition, RNESL has also agreed to invest GBP 25 million as growth capital to accelerate commercial roll out.

“Based out of Sheffield and Oxford in U.K. and with its patented sodium-ion battery technology, Faradion is one of the leading global battery technology companies. It has a competitively superior, strategic, wide-reaching and extensive IP portfolio covering several aspects of sodium-ion technology,” RIL said in a statement.

** IIT Madras tops in Atal innovation rankings

Seven IITs, IISc, figure among top 10

Seven Indian Institutes of Technology and Indian Institute of Science, Bengaluru, are among the top 10 central institutions in promotion and support of innovation and entrepreneurship development, according to Atal Ranking of Institutions on Innovation Achievements (ARIIA) announced on Wednesday.

The top rank has been bagged by IIT Madras followed by IIT Bombay, IIT Delhi, IIT Kanpur and IIT Roorkee.

** Kerala best State on health parameters, Uttar Pradesh worst: NITI Aayog

TN, Telangana in top three across parameters; U.P. remains at bottom

For the fourth year in a row, Kerala has topped a ranking of States on health indicators; Uttar Pradesh has come in at the bottom. The ‘Health Index’ is part of a report commissioned by the NITI Aayog, World Bank and Ministry of Health and Family Welfare.

Kerala was followed by Tamil Nadu and Telangana.

** Two more vaccines and a drug join India’s fight against COVID-19

Corbevax, Covovax shots and Molnupiravir get emergency use authorisation.

India has approved two more vaccines under emergency use authorisation and an antiviral drug, Molnupiravir, Health Minister Mansukh Mandaviya tweeted on Tuesday. Currently, India uses Covishield, Covaxin and Sputnik V in its vaccination programme.

Corbevax to be made by Hyderabad-based Biological-E is a protein sub-unit vaccine and Covovax, to be manufactured by Serum Institute of India, Pune, is a nanoparticle-based vaccine.

Corbevax is co-developed by Biological E, Baylor College of Medicine in Houston, United States, and American company Dynavax Technologies.

Covovax is produced by the Serum Institute of India under licence from Novavax, a U.S.-based biotechnology company. Covovax has been approved by the World Health Organisation (WHO) under its Emergency Use Listing and, therefore, will also be available globally as part of the COVAX initiative to ensure that at least 40% of world is vaccinated on priority.

Molnupiravir, that was approved this month by the U.S. Food and Drugs Administration (U.S. FDA), on the heels of Paxlovid by Pfizer Inc, is said to be a promising drug for those with mild and moderate disease and also easily administered as a pill. Thirteen companies in India are set to manufacture this drug. It has been approved under emergency use authorisation for treating adults with COVID-19 “who have high risk of progression to disease”.

** Maiden test of Pralay surface-to-surface missile successful

The solid-fuel, battlefield missile developed by the DRDO is based on Prithvi Defence Vehicle from the Indian ballistic missile programme.

The Defence Research and Development Organisation (DRDO) on Wednesday successfully conducted the maiden flight test of indigenously developed surface-to-surface missile ‘Pralay’, from Dr A.P.J. Abdul Kalam Island off Odisha coast.